Skip to main content
Helixmith Co., Ltd logo

Helixmith Co., Ltd — Investor Relations & Filings

Ticker · 084990 ISIN · KR7084990001 KO Manufacturing
Filings indexed 508 across all filing types
Latest filing 2021-05-31 Report Publication Anno…
Country KR South Korea
Listing KO 084990

About Helixmith Co., Ltd

https://www.helixmith.com/

Helixmith is a biotechnology company specializing in the research and development of gene therapies. Established in 1996, the company focuses on creating innovative biopharmaceuticals for diseases with significant unmet medical needs. Its core activities revolve around an extensive pipeline of next-generation gene therapy products. The primary therapeutic areas of focus include neurological and cardiovascular disorders, such as peripheral artery disease and coronary artery disease. Helixmith manages a comprehensive range of capabilities, from discovery and preclinical studies to clinical development of its drug candidates.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement (871 characters) regarding the scheduling of an Investor Relations (IR) event (Non-Deal Roadshow). It provides details such as date, location, purpose, and contact information for an upcoming meeting. It does not contain the actual presentation slides or the full financial report, but rather serves as a notification of the event's occurrence. Therefore, it falls under the category of a regulatory announcement regarding company activities.
2021-05-31 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for the company Helixmith, dated May 25, 2021. It outlines the date, time, location, and agenda items (such as board member appointments and articles of incorporation changes) for the upcoming meeting. This type of document, which provides information to shareholders regarding an upcoming meeting and requests their participation/vote, is classified as a Proxy Solicitation & Information Statement.
2021-05-25 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company Helixmith, covering the period from January 1, 2021, to March 31, 2021. It contains detailed financial information, business operations, management discussion, and corporate governance data, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-05-17 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short regulatory announcement (811 characters) from Helixmith regarding the scheduling and details of an Investor Relations (IR) meeting/presentation. It provides the date, time, location, and purpose of the meeting. Since it is an announcement of an event rather than the presentation slides themselves, and it is a regulatory filing regarding corporate activity, it fits the definition of a Regulatory Filing (RNS) or a general announcement.
2021-04-30 Korean
풍문또는보도에대한해명(최종 답변)
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) titled 'Clarification on Rumors or Reports'. It addresses specific media reports regarding management changes (CEO resignation plans) and provides an official company response. Since it is a regulatory announcement regarding corporate affairs that does not fit into specific categories like M&A, Board changes (it is a clarification of rumors about them), or financial reports, it falls under the general regulatory filing category.
2021-04-14 Korean
불성실공시법인지정(공시불이행)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory notice regarding the designation of the company as an 'unfaithful disclosure corporation' (불성실공시법인) due to a delay in disclosing litigation. It details the penalty points and regulatory grounds for this action. Since this is a specific regulatory announcement regarding compliance and disclosure violations that does not fit into financial reporting or corporate action categories, it is classified as a Regulatory Filing (RNS).
2021-04-06 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.